INT188250

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.45
First Reported 2005
Last Reported 2005
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.42
Pain Relevance 0.09

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (RPS6KA1) nucleoplasm (RPS6KA1) signal transduction (RPS6KA1)
nucleus (RPS6KA1) cell cycle (RPS6KA1) response to stress (RPS6KA1)
RPS6KA1 (Homo sapiens)
Pain Link Frequency Relevance Heat
aspirin 2 86.80 High High
beta blocker 1 85.84 High High
cva 3 5.00 Very Low Very Low Very Low
withdrawal 1 5.00 Very Low Very Low Very Low
Angina 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
headache 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Adverse Drug Reaction 38 73.04 Quite High
Pressure Volume 2 Under Development 9 70.16 Quite High
Myocardial Infarction 18 58.40 Quite High
Unconsciousness 1 51.20 Quite High
Death 8 5.00 Very Low Very Low Very Low
Hypersensitivity 6 5.00 Very Low Very Low Very Low
Vomiting 5 5.00 Very Low Very Low Very Low
Stroke 5 5.00 Very Low Very Low Very Low
Hemorrhage 5 5.00 Very Low Very Low Very Low
Chills 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Although rSK has been approved for routine use within 12 h, 18 patients were reported as receiving the drug after 12 h of symptoms onset.
Positive_regulation (approved) of rSK
1) Confidence 0.45 Published 2005 Journal BMC Clin Pharmacol Section Body Doc Link PMC1291362 Disease Relevance 0.42 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox